Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation

NCT01714310 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Severe Mood Dysregulation

Interventions

DRUG: lisdexamfetamine
DRUG: Placebo
DRUG: fluoxetine

Sponsor

University of California, Los Angeles

Collaborators

[object Object]
[object Object]